Kenvue Inc. (NYSE:KVUE) Receives Average Recommendation of "Hold" from Analysts

Kenvue Inc. (NYSE:KVUE - Get Free Report) has been given a consensus recommendation of "Hold" by the twelve ratings firms that are currently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, seven have given a hold recommendation and four have issued a buy recommendation on the company. The average 1 year target price among brokers that have updated their coverage on the stock in the last year is $22.64.

KVUE has been the subject of several recent research reports. Deutsche Bank Aktiengesellschaft raised their price target on shares of Kenvue from $23.00 to $24.00 and gave the company a "buy" rating in a research report on Wednesday, August 7th. JPMorgan Chase & Co. boosted their target price on Kenvue from $24.00 to $25.00 and gave the stock an "overweight" rating in a research note on Friday, October 11th. Bank of America increased their price target on Kenvue from $24.00 to $27.00 and gave the company a "buy" rating in a research report on Tuesday, October 22nd. UBS Group boosted their price objective on Kenvue from $20.00 to $22.00 and gave the stock a "neutral" rating in a research report on Wednesday, August 7th. Finally, Piper Sandler raised their target price on shares of Kenvue from $20.00 to $21.00 and gave the company a "neutral" rating in a report on Monday, September 23rd.

Hedge Funds Weigh In On Kenvue

Large investors have recently bought and sold shares of the stock. State Street Corp boosted its holdings in shares of Kenvue by 16.8% in the third quarter. State Street Corp now owns 127,213,940 shares of the company's stock valued at $2,942,458,000 after acquiring an additional 18,283,473 shares during the period. Van ECK Associates Corp grew its position in Kenvue by 110.9% during the 2nd quarter. Van ECK Associates Corp now owns 20,510,427 shares of the company's stock worth $372,880,000 after purchasing an additional 10,783,258 shares during the last quarter. Bank of New York Mellon Corp increased its stake in Kenvue by 21.0% in the second quarter. Bank of New York Mellon Corp now owns 43,444,085 shares of the company's stock valued at $789,813,000 after purchasing an additional 7,546,362 shares during the period. Massachusetts Financial Services Co. MA raised its holdings in shares of Kenvue by 8.9% in the third quarter. Massachusetts Financial Services Co. MA now owns 86,979,341 shares of the company's stock valued at $2,011,832,000 after buying an additional 7,115,374 shares during the last quarter. Finally, Holocene Advisors LP raised its holdings in shares of Kenvue by 75.5% in the third quarter. Holocene Advisors LP now owns 13,886,454 shares of the company's stock valued at $321,194,000 after buying an additional 5,975,392 shares during the last quarter. Institutional investors and hedge funds own 97.64% of the company's stock.

Kenvue Trading Down 0.2 %

Shares of KVUE stock traded down $0.05 during trading hours on Friday, hitting $24.08. The company had a trading volume of 7,516,546 shares, compared to its average volume of 17,823,225. Kenvue has a fifty-two week low of $17.67 and a fifty-two week high of $24.46. The company's fifty day moving average is $22.94 and its 200 day moving average is $20.99. The stock has a market capitalization of $46.17 billion, a PE ratio of 43.78, a price-to-earnings-growth ratio of 2.19 and a beta of 1.36. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.00 and a quick ratio of 0.69.

Kenvue (NYSE:KVUE - Get Free Report) last released its earnings results on Thursday, November 7th. The company reported $0.28 earnings per share for the quarter, beating the consensus estimate of $0.27 by $0.01. The company had revenue of $3.90 billion during the quarter, compared to the consensus estimate of $3.92 billion. Kenvue had a return on equity of 21.43% and a net margin of 6.88%. Kenvue's revenue was down .4% compared to the same quarter last year. During the same period in the previous year, the company posted $0.31 EPS. Research analysts expect that Kenvue will post 1.07 earnings per share for the current fiscal year.

Kenvue Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, November 27th. Investors of record on Wednesday, November 13th were paid a dividend of $0.205 per share. The ex-dividend date of this dividend was Wednesday, November 13th. This represents a $0.82 annualized dividend and a yield of 3.41%. Kenvue's dividend payout ratio is currently 149.09%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.